Navinci has developed a "Proximity Ligation" technological platform to analyze and quantify proteins in situ at the molecular level in the natural environment of the cell:
•   Detection of protein-protein interactions
•   Specific detection of post-translational modifications
•   Ability to detect extremely low abundance proteins, without overexpressing the protein of interest
•   Analysis directly in a single cell or within a tissue (diseased or tumourous)

Applications: Immuno-profiling, signalling profiling, drug testing, treatments validation, biomarkers discovery, etc.
Proximity Ligation technology provides better sensitivity and specificity than PLA technology
The Austrian company specializes in particular in transcriptome profiling solutions and the analysis of NGS data.

Some of the exclusive technologies developed by Lexogen include:
•   QuantSeq 3‘ mRNA-Seq Library Prep : preparation of mRNA-Seq 3’ libraries
•   RiboCop rRNA Depletion : efficient depletion of ribosomal RNAs upstream of NGS
•   CORALL Total RNA-Seq Library Prep : preparation of “whole transcriptome” libraries
Codex DNA's mission is to equip scientific researchers with the necessary methodologies to quickly and accurately produce large quantities of synthetic genes. Ozyme completes its offering on cloning solutions by integrating products from Codex DNA, a company co-founded by Dan Gibson, the inventor of Gibson cloning technology recognized as the gold standard, into its catalog.
Gibson Assembly® kits are the most recent versions generating the best cloning efficiency.

The product portfolio also includes Vmax ™ competent cells for the production of proteins in bacteria. This system makes it possible to generate significantly larger quantities of biomass than traditional systems for the expression of bacterial proteins.